% alzhub.org topic: hydromethylthionine
% Source: https://alzhub.org/topic/hydromethylthionine
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{wischik2022-36281683,
  author  = {Wischik, C. M. and Bentham, P. and Gauthier, S. and Miller, S. and Kook, K. and Schelter, B. O.},
  title   = {{Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.63},
  pmid    = {36281683},
  url     = {https://doi.org/10.14283/jpad.2022.63}
}

@article{schwab2021-34440931,
  author  = {Schwab, K. and Melis, V. and Harrington, C. R. and Wischik, C. M. and Magbagbeolu, M. and Theuring, F. and Riedel, G.},
  title   = {{Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks}},
  journal = {Cells},
  year    = {2021},
  doi     = {10.3390/cells10082162},
  pmid    = {34440931},
  url     = {https://doi.org/10.3390/cells10082162}
}

@article{schelter2019-31658058,
  author  = {Schelter, B. O. and Shiells, H. and Baddeley, T. C. and Rubino, C. M. and Ganesan, H. and Hammel, J. and Vuksanovic, V. and Staff, R. T. and others},
  title   = {{Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2019},
  doi     = {10.3233/jad-190772},
  pmid    = {31658058},
  url     = {https://doi.org/10.3233/jad-190772}
}